Press

• 

  Press

  New Standard for Parkinson’s Diagnostics – German Biotech Company MODAG Unveils World’s First CE-Certified Test Kit

  Artikel lesen
• 

  Press

  Rhineland-Palatinate biotech company MODAG receives research grant funding from The Michael J. Fox Foundation

  Artikel lesen
• 

  Press

  Rhineland-Palatinate biotech company MODAG GmbH celebrates Fast Track designation in the USA

  Artikel lesen
• 

  Press

  Teva and MODAG Announce Licensing Collaboration

  Artikel lesen
• 

  Press

  MODAG Initiates First-in-Patient Phase 1b Trial for Anle138b in Parkinson´s Disease

  Artikel lesen
• 

  Press

  MODAG Successfully Completes Phase 1 Study of their Lead Candidate Anle138b

  Artikel lesen
• 

  Press

  MODAG Initiates First-in-Human Phase 1 Clinical Trial for Anle138b

  Artikel lesen
• 

  Press

  MODAG Appoints Dr. Johannes Levin as Chief Medical Officer

  Artikel lesen
• 

  Press

  MODAG Launches Out of Stealth Mode with Series A Financing of EUR 12 Million

  Artikel lesen